IDIX

IDENIX PHARMACEUTICALS INCCIK 1093649 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for IDIX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for IDIX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
KLARMAN SETH A	10% Owner	1	$0	$0	2014-08-05
Dumas Jacques	EVP, Chief Scientific Officer	1	$0	$0	2014-08-05
Beckman Daniella	SVP, CFO and Treasurer	11	$0	$0	2014-08-05
Stahl Maria D	SVP & General Counsel	8	$0	$0	2014-08-05
Fanning Paul	SVP, Human Resources	16	$0	$331.2K	2014-08-05
Mayers Douglas L	EVP and Chief Medical Officer	12	$0	$0	2014-08-05
Rowland Charles A Jr	Director	6	$0	$0	2014-08-05
Renaud Ronald C JR	President & CEO	19	$0	$0	2014-08-05
Pollard-Knight Denise	Director	12	$0	$0	2014-08-05
HOCKMEYER WAYNE T	Director	13	$0	$0	2014-08-05
HOWSON TAMAR D	Director	10	$0	$0	2014-08-05
WYZGA MICHAEL S	Director	10	$0	$0	2014-08-05
HODGSON THOMAS R	Director	13	$0	$0	2014-08-05
NOVARTIS PHARMA AG	10% Owner	20	$291.3K	$0	2014-08-05
SAK CORP	10% Owner	1	$106.73M	$0	2014-01-31
Standring David	EVP & Chief Scientific Officer	2	$0	$0	2013-02-20

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Beckman Daniella	SVP, CFO and Treasurer	D To issuer deriv	2014-08-05	2014-08-05	30,000	—	$0	0	SEC↗
Beckman Daniella	SVP, CFO and Treasurer	D To issuer deriv	2014-08-05	2014-08-05	100,000	—	$0	0	SEC↗
Beckman Daniella	SVP, CFO and Treasurer	D To issuer deriv	2014-08-05	2014-08-05	100,000	—	$0	0	SEC↗
Beckman Daniella	SVP, CFO and Treasurer	D To issuer deriv	2014-08-05	2014-08-05	50,000	—	$0	0	SEC↗
Beckman Daniella	SVP, CFO and Treasurer	D To issuer deriv	2014-08-05	2014-08-05	100,000	—	$0	0	SEC↗
Beckman Daniella	SVP, CFO and Treasurer	D To issuer deriv	2014-08-05	2014-08-05	7,500	—	$0	0	SEC↗
Beckman Daniella	SVP, CFO and Treasurer	D To issuer deriv	2014-08-05	2014-08-05	6,000	—	$0	0	SEC↗
Beckman Daniella	SVP, CFO and Treasurer	D To issuer deriv	2014-08-05	2014-08-05	15,000	—	$0	0	SEC↗
Dumas Jacques	EVP, Chief Scientific Office	D To issuer deriv	2014-08-05	2014-08-05	250,000	—	$0	0	SEC↗
Fanning Paul	SVP, Human Resources	D To issuer deriv	2014-08-05	2014-08-05	15,000	—	$0	0	SEC↗
Fanning Paul	SVP, Human Resources	D To issuer deriv	2014-08-05	2014-08-05	15,000	—	$0	0	SEC↗
Fanning Paul	SVP, Human Resources	D To issuer deriv	2014-08-05	2014-08-05	15,000	—	$0	0	SEC↗
Fanning Paul	SVP, Human Resources	D To issuer deriv	2014-08-05	2014-08-05	80,000	—	$0	0	SEC↗
Fanning Paul	SVP, Human Resources	D To issuer deriv	2014-08-05	2014-08-05	60,000	—	$0	0	SEC↗
Fanning Paul	SVP, Human Resources	D To issuer deriv	2014-08-05	2014-08-05	60,000	—	$0	0	SEC↗
Fanning Paul	SVP, Human Resources	D To issuer deriv	2014-08-05	2014-08-05	40,000	—	$0	0	SEC↗
Fanning Paul	SVP, Human Resources	D To issuer deriv	2014-08-05	2014-08-05	35,000	—	$0	0	SEC↗
Fanning Paul	SVP, Human Resources	D To issuer deriv	2014-08-05	2014-08-05	30,000	—	$0	0	SEC↗
Fanning Paul	SVP, Human Resources	D To issuer deriv	2014-08-05	2014-08-05	40,000	—	$0	0	SEC↗
Mayers Douglas L	EVP and Chief Medical Office	D To issuer deriv	2014-08-05	2014-08-05	40,000	—	$0	0	SEC↗
Mayers Douglas L	EVP and Chief Medical Office	D To issuer deriv	2014-08-05	2014-08-05	100,000	—	$0	0	SEC↗
Mayers Douglas L	EVP and Chief Medical Office	D To issuer deriv	2014-08-05	2014-08-05	80,000	—	$0	0	SEC↗
Mayers Douglas L	EVP and Chief Medical Office	D To issuer deriv	2014-08-05	2014-08-05	40,000	—	$0	0	SEC↗
Mayers Douglas L	EVP and Chief Medical Office	D To issuer deriv	2014-08-05	2014-08-05	40,000	—	$0	0	SEC↗
Mayers Douglas L	EVP and Chief Medical Office	D To issuer deriv	2014-08-05	2014-08-05	60,000	—	$0	0	SEC↗
Mayers Douglas L	EVP and Chief Medical Office	D To issuer deriv	2014-08-05	2014-08-05	125,000	—	$0	0	SEC↗
Mayers Douglas L	EVP and Chief Medical Office	D To issuer deriv	2014-08-05	2014-08-05	120,000	—	$0	0	SEC↗
Mayers Douglas L	EVP and Chief Medical Office	D To issuer deriv	2014-08-05	2014-08-05	100,000	—	$0	0	SEC↗
Renaud Ronald C JR	President & CEO	D To issuer deriv	2014-08-05	2014-08-05	110,000	—	$0	0	SEC↗
Renaud Ronald C JR	President & CEO	D To issuer deriv	2014-08-05	2014-08-05	80,000	—	$0	0	SEC↗
Renaud Ronald C JR	President & CEO	D To issuer deriv	2014-08-05	2014-08-05	225,000	—	$0	0	SEC↗
Renaud Ronald C JR	President & CEO	D To issuer deriv	2014-08-05	2014-08-05	10	—	$0	0	SEC↗
Renaud Ronald C JR	President & CEO	D To issuer deriv	2014-08-05	2014-08-05	65,000	—	$0	0	SEC↗
Renaud Ronald C JR	President & CEO	D To issuer deriv	2014-08-05	2014-08-05	375,000	—	$0	0	SEC↗
Renaud Ronald C JR	President & CEO	D To issuer deriv	2014-08-05	2014-08-05	500,000	—	$0	0	SEC↗
Renaud Ronald C JR	President & CEO	D To issuer deriv	2014-08-05	2014-08-05	300,000	—	$0	0	SEC↗
Renaud Ronald C JR	President & CEO	D To issuer deriv	2014-08-05	2014-08-05	300,000	—	$0	0	SEC↗
Renaud Ronald C JR	President & CEO	D To issuer deriv	2014-08-05	2014-08-05	400,000	—	$0	0	SEC↗
Stahl Maria D	SVP & General Counsel	D To issuer deriv	2014-08-05	2014-08-05	100,000	—	$0	0	SEC↗
Stahl Maria D	SVP & General Counsel	D To issuer deriv	2014-08-05	2014-08-05	100,000	—	$0	0	SEC↗
Stahl Maria D	SVP & General Counsel	D To issuer deriv	2014-08-05	2014-08-05	80,000	—	$0	0	SEC↗
Stahl Maria D	SVP & General Counsel	D To issuer deriv	2014-08-05	2014-08-05	150,000	—	$0	0	SEC↗
Stahl Maria D	SVP & General Counsel	D To issuer deriv	2014-08-05	2014-08-05	100,000	—	$0	0	SEC↗
HOCKMEYER WAYNE T	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HOCKMEYER WAYNE T	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HOCKMEYER WAYNE T	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HOCKMEYER WAYNE T	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HOCKMEYER WAYNE T	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HOCKMEYER WAYNE T	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HOCKMEYER WAYNE T	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HOCKMEYER WAYNE T	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HOCKMEYER WAYNE T	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HOCKMEYER WAYNE T	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HODGSON THOMAS R	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HODGSON THOMAS R	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HODGSON THOMAS R	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HODGSON THOMAS R	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HODGSON THOMAS R	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HODGSON THOMAS R	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HODGSON THOMAS R	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HODGSON THOMAS R	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HODGSON THOMAS R	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HODGSON THOMAS R	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HOWSON TAMAR D	Director	D To issuer deriv	2014-08-05	2014-08-05	15,000	—	$0	0	SEC↗
HOWSON TAMAR D	Director	D To issuer deriv	2014-08-05	2014-08-05	3,333	—	$0	0	SEC↗
HOWSON TAMAR D	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HOWSON TAMAR D	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HOWSON TAMAR D	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HOWSON TAMAR D	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
HOWSON TAMAR D	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
Pollard-Knight Denise	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
Pollard-Knight Denise	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
Pollard-Knight Denise	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
Pollard-Knight Denise	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
Pollard-Knight Denise	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
Pollard-Knight Denise	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
Pollard-Knight Denise	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
Pollard-Knight Denise	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
Pollard-Knight Denise	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
Rowland Charles A Jr	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
Rowland Charles A Jr	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
Rowland Charles A Jr	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
WYZGA MICHAEL S	Director	D To issuer deriv	2014-08-05	2014-08-05	15,000	—	$0	0	SEC↗
WYZGA MICHAEL S	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
WYZGA MICHAEL S	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
WYZGA MICHAEL S	Director	D To issuer deriv	2014-08-05	2014-08-05	5,000	—	$0	0	SEC↗
WYZGA MICHAEL S	Director	D To issuer deriv	2014-08-05	2014-08-05	20,000	—	$0	0	SEC↗
NOVARTIS PHARMA AG	10% Owner	U Tender	2014-08-05	2014-08-12	33,320,674	$24.50	$816.36M	0	SEC↗
KLARMAN SETH A	10% Owner	J Other	2014-08-05	2014-08-12	53,331,109	$24.50	$1.31B	0	SEC↗
Renaud Ronald C JR	President & CEO	J Other	2014-06-19	2014-07-11	89,990	—	$0	89,990	SEC↗
HOCKMEYER WAYNE T	Director	A Award deriv	2014-06-05	2014-06-06	20,000	—	$0	20,000	SEC↗
HODGSON THOMAS R	Director	A Award deriv	2014-06-05	2014-06-06	20,000	—	$0	20,000	SEC↗
HOWSON TAMAR D	Director	A Award deriv	2014-06-05	2014-06-06	20,000	—	$0	20,000	SEC↗
Pollard-Knight Denise	Director	A Award deriv	2014-06-05	2014-06-06	20,000	—	$0	20,000	SEC↗
Rowland Charles A Jr	Director	A Award deriv	2014-06-05	2014-06-06	20,000	—	$0	20,000	SEC↗
WYZGA MICHAEL S	Director	A Award deriv	2014-06-05	2014-06-06	20,000	—	$0	20,000	SEC↗
Renaud Ronald C JR	President & CEO	G Gift	2014-06-04	2014-07-11	89,990	—	$0	0	SEC↗
Renaud Ronald C JR	President & CEO	A Award deriv	2014-02-11	2014-02-12	400,000	—	$0	400,000	SEC↗
Beckman Daniella	SVP, CFO and Treasurer	A Award deriv	2014-02-10	2014-02-12	100,000	—	$0	100,000	SEC↗
Fanning Paul	SVP, Human Resources	A Award deriv	2014-02-10	2014-02-12	80,000	—	$0	80,000	SEC↗
Mayers Douglas L	EVP and Chief Medical Office	A Award deriv	2014-02-10	2014-02-12	100,000	—	$0	100,000	SEC↗
Stahl Maria D	SVP & General Counsel	A Award deriv	2014-02-10	2014-02-12	100,000	—	$0	100,000	SEC↗
SAK CORP	10% Owner	P Buy	2014-01-31	2014-02-04	16,420,241	$6.50	$106.73M	53,331,109	SEC↗
HOCKMEYER WAYNE T	Director	A Award deriv	2013-06-06	2013-06-10	20,000	—	$0	20,000	SEC↗
HODGSON THOMAS R	Director	A Award deriv	2013-06-06	2013-06-10	20,000	—	$0	20,000	SEC↗
HOWSON TAMAR D	Director	A Award deriv	2013-06-06	2013-06-10	20,000	—	$0	20,000	SEC↗
Pollard-Knight Denise	Director	A Award deriv	2013-06-06	2013-06-10	20,000	—	$0	20,000	SEC↗
WYZGA MICHAEL S	Director	A Award deriv	2013-06-06	2013-06-10	20,000	—	$0	20,000	SEC↗
Rowland Charles A Jr	Director	A Award deriv	2013-06-06	2013-06-10	20,000	—	$0	20,000	SEC↗
Rowland Charles A Jr	Director	A Award deriv	2013-06-06	2013-06-10	20,000	—	$0	20,000	SEC↗
Renaud Ronald C JR	President & CEO	A Award deriv	2013-02-21	2013-02-22	500,000	—	$0	500,000	SEC↗
Beckman Daniella	SVP, CFO and Treasurer	A Award deriv	2013-02-20	2013-02-22	100,000	—	$0	100,000	SEC↗
Fanning Paul	SVP, Human Resources	A Award deriv	2013-02-20	2013-02-22	60,000	—	$0	60,000	SEC↗
Mayers Douglas L	EVP and Chief Medical Office	A Award deriv	2013-02-20	2013-02-22	120,000	—	$0	120,000	SEC↗
Stahl Maria D	SVP & General Counsel	A Award deriv	2013-02-20	2013-02-22	100,000	—	$0	100,000	SEC↗
Standring David	EVP & Chief Scientific Offic	A Award deriv	2013-02-20	2013-02-22	95,000	—	$0	95,000	SEC↗
Renaud Ronald C JR	President & CEO	M Exercise deriv	2012-12-14	2012-12-17	35,000	—	$0	65,000	SEC↗
Renaud Ronald C JR	President & CEO	M Exercise deriv	2012-12-14	2012-12-17	39,990	—	$0	10	SEC↗
Renaud Ronald C JR	President & CEO	M Exercise	2012-12-14	2012-12-17	35,000	$2.96	$103.6K	89,990	SEC↗
Renaud Ronald C JR	President & CEO	M Exercise	2012-12-14	2012-12-17	39,990	$2.41	$96.4K	54,990	SEC↗
HOCKMEYER WAYNE T	Director	A Award deriv	2012-06-07	2012-06-11	20,000	—	$0	20,000	SEC↗
HODGSON THOMAS R	Director	A Award deriv	2012-06-07	2012-06-11	20,000	—	$0	20,000	SEC↗
HOWSON TAMAR D	Director	A Award deriv	2012-06-07	2012-06-11	20,000	—	$0	20,000	SEC↗
Pollard-Knight Denise	Director	A Award deriv	2012-06-07	2012-06-11	20,000	—	$0	20,000	SEC↗
WYZGA MICHAEL S	Director	A Award deriv	2012-06-07	2012-06-11	20,000	—	$0	20,000	SEC↗
Fanning Paul	SVP, Human Resources	M Exercise deriv	2012-03-16	2012-03-20	30,000	—	$0	0	SEC↗
Fanning Paul	SVP, Human Resources	S Sale	2012-03-16	2012-03-20	30,000	$11.04	$331.2K	1,300	SEC↗
Fanning Paul	SVP, Human Resources	M Exercise	2012-03-16	2012-03-20	30,000	$2.41	$72.3K	31,300	SEC↗
WYZGA MICHAEL S	Director	A Award deriv	2012-03-01	2012-03-02	5,000	—	$0	5,000	SEC↗
WYZGA MICHAEL S	Director	A Award deriv	2012-03-01	2012-03-02	15,000	—	$0	15,000	SEC↗
Renaud Ronald C JR	President & CEO	A Award deriv	2012-03-01	2012-03-02	375,000	—	$0	375,000	SEC↗
Beckman Daniella	SVP, CFO and Treasurer	A Award deriv	2012-02-29	2012-03-02	100,000	—	$0	100,000	SEC↗
Fanning Paul	SVP, Human Resources	A Award deriv	2012-02-29	2012-03-02	60,000	—	$0	60,000	SEC↗
Mayers Douglas L	EVP and Chief Medical Office	A Award deriv	2012-02-29	2012-03-02	125,000	—	$0	125,000	SEC↗
Stahl Maria D	SVP & General Counsel	A Award deriv	2012-02-29	2012-03-02	100,000	—	$0	100,000	SEC↗
Standring David	EVP & Chief Scientific Offic	A Award deriv	2012-02-29	2012-03-02	125,000	—	$0	125,000	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	427	$2.97	$1.3K	33,290,194	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	8,960	$2.96	$26.5K	33,289,767	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	997	$2.78	$2.8K	33,276,369	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	1,321	$2.85	$3.8K	33,277,690	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	3,117	$2.90	$9.0K	33,280,807	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	997	$2.69	$2.7K	33,275,372	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	2,493	$2.56	$6.4K	33,274,375	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	366	$2.47	$904	33,271,882	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	35,735	$2.41	$86.1K	33,271,516	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	2,133	$7.39	$15.8K	33,320,674	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	493	$6.52	$3.2K	33,318,541	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	436	$5.80	$2.5K	33,318,048	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	883	$5.79	$5.1K	33,317,612	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	7,402	$5.46	$40.4K	33,316,729	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	11,433	$5.11	$58.4K	33,309,327	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	39	$5.10	$199	33,297,894	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	3,093	$3.79	$11.7K	33,297,855	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	4,336	$3.17	$13.7K	33,294,762	SEC↗
NOVARTIS PHARMA AG	10% Owner	P Buy	2012-02-23	2012-02-23	232	$3.04	$705	33,290,426	SEC↗